Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: A prospective five-year study

Heart

Volumn 94, Issue 11, 2008, Pages 1450-1455

  Tribouilloy, Christophe ^a,b,e   Rusinaru, D ^a,b   Mahjoub, H ^a,b   Tartiere J M ^c   Kesri Tartiere L ^d   Godard, S ^a,b   Peltier, M ^a,b  

^a INSERM   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d BICHAT HOSPITAL   (France)

^e Department of Cardiology ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; METFORMIN; NITRATE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; FRANCE; HEART FAILURE; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 54349105448     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.128769     Document Type: Article

References (28)

1. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-33.
2. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;214:2035-8.
3. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570- 81.
4. De Groote P, Lamblin N, Mouquet F, et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 2004;25:656-62.
5. Gustafsson I, Brendorp B, Seibaek M, et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 2004;43:771-7.
6. Dries DL, Sweitzer NK, Drazner MH, et al. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 2001;38:421-8.
7. From AM, Leibson CL, Bursi F, et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 2006;119:591-9.
8. Domanski M, Krause-Steinrauf H, Deedwania P, et al. The effect of diabetes on outcome of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol 2003;42:914-22.
9. American Heart Association. Heart disease and stroke statistics, 2004 update. Dallas, TX: American Heart Association, 2004. www.americanheart.org/downloadable/heart/1079736729696HDSStats2004UpdateREV3-19- 04.pdf (accessed 29 Jun 2007).
10. Shindler DM, Kostis JB, Yusuf S, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry. Am J Cardiol 1996;77:1017-20.
11. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
12. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9.
13. Varela-Roman A, Grigorian Shamagian L, Barge E, et al. Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study. Eur J Heart Fail 2005;7:859-64.
14. The Task Force on Heart Failure of the European Society of Cardiology Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-51.
15. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101:2118-21.
16. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on clinical application of echocardiography). Circulation 1997;95:1686-744.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
18. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota in 1991. Circulation 1998;98:2282-9.
19. Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999;20:421-8.
20. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22:6A-13A.
21. Tenenbaum A, Motro M, Fisman EZ, et al. Functional class in patients with heart failure is associated with the development of diabetes. Am J Med 2003;114: 271-5.
22. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
23. Simon T, Mary-Krause M, Funck-Brentano C, et al. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2001;103:375-80.
24. Ryden L, Armstrong PW, Cleland J, et al. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J 2000;21:1967-78.
25. Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population: the Rotterdam study. Eur Heart J 2001;22:1318-27.
26. Berry C, Norrie J, Brett M, et al. Nature and prognostic importance of abnormal glucose tolerance and diabetes in heart failure. Heart 2008;94:296-304.
27. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
28. Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus. A population-based autopsy study. J Am Coll Cardiol 2002;40:946-53.